Clear Creek Financial Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Clear Creek Financial Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	BUY	$680.49 - $826.97 $38,787 - $47,137	57 Added 5.76%	1,047 $860,000
Q4 2022 Jan 23, 2023	BUY	$705.89 - $766.39 $46,588 - $50,581	66 Added 7.14%	990 $0
Q3 2022 Oct 24, 2022	SELL	$573.97 - $724.32 $4,017 - $5,070	-7 Reduced 0.75%	924 $637,000
Q2 2022 Jul 27, 2022	BUY	$548.35 - $738.84 $37,836 - $50,979	69 Added 8.0%	931 $550,000
Q1 2022 May 02, 2022	SELL	$595.12 - $698.43 $35,112 - $41,207	-59 Reduced 6.41%	862 $602,000
Q4 2021 Jan 21, 2022	SELL	$543.48 - $670.97 $338,588 - $418,014	-623 Reduced 40.35%	921 $582,000
Q3 2021 Oct 14, 2021	BUY	$574.03 - $680.96 $208,372 - $247,188	363 Added 30.74%	1,544 $934,000
Q2 2021 Jul 30, 2021	BUY	$472.8 - $558.54 $558,376 - $659,635	1,181 New	1,181 $660,000
Q3 2020 Nov 10, 2020	SELL	$544.75 - $658.21 $317,589 - $383,736	-583 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$493.32 - $643.92 $287,605 - $375,405	583 New	583 $363,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Creek Financial Management, LLC with notifications on news.